Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
"Putting the power back into community": A mixed methods evaluation of a chronic hepatitis B training course for the Aboriginal health workforce of Australia's Northern Territory.
Hosking K, De Santis T, Vintour-Cesar E, Wilson PM, Bunn L, Garambaka Gurruwiwi G, Wurrawilya S, Bukulatjpi SM, Nelson S, Ross C, Stuart-Carter KA, Ngurruwuthun T, Dhagapan A, Binks P, Sullivan R, Ward L, Schroder P, Tate-Baker J, Davis JS, Connors C, Davies J; Hep B PAST partnership. Hosking K, et al. Among authors: davies j. PLoS One. 2024 Jan 24;19(1):e0288577. doi: 10.1371/journal.pone.0288577. eCollection 2024. PLoS One. 2024. PMID: 38266007 Free PMC article.
Adapting and translating the 'Hep B Story' App the right way: A transferable toolkit to develop health resources with, and for, Aboriginal people.
Binks P, Ross C, Gurruwiwi GG, Wurrawilya S, Alley T, Bukulatjpi SM, Vintour-Cesar E, Hosking K, Davis JS, Hefler M, Davies J; Hep B PAST Partnership Group. Binks P, et al. Among authors: davies j. Health Promot J Austr. 2024 Oct;35(4):1244-1254. doi: 10.1002/hpja.858. Epub 2024 Apr 2. Health Promot J Austr. 2024. PMID: 38566264
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia.
Wang DS, Phu A, McKee K, Strasser SI, Sheils S, Weltman M, Sellar S, Davis JS, Young M, Braund A, Farrell GC, Blunn A, Harding D, Ralton L, Muller K, Davison SA, Shaw D, Wood M, Hajkowicz K, Skolen R, Davies J, Tate-Baker J, Doyle A, Tuma R, Hazeldine S, Lam W, Edmiston N, Zohrab K, Pratt W, Watson B, Zekry A, Stephens C, Clark PJ, Day M, Park G, Kim H, Wilson M, McGarity B, Menzies N, Russell D, Lam T, Boyd P, Kok J, George J, Douglas MW. Wang DS, et al. Among authors: davies j. Open Forum Infect Dis. 2024 Mar 18;11(4):ofae155. doi: 10.1093/ofid/ofae155. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38651137 Free PMC article.
An evaluation and refinement of the "Hep B Story" app, tailored to meet the community's cultural needs.
Binks P, Venkatesan S, Everitt A, Gurruwiwi GG, Dhurrkay RG, Bukulatjpi SM, Ross C, Alley T, Hosking K, Vintour-Cesar E, McKinnon M, Sullivan RP, Davis JS, Hefler M, Davies J; Hep B PAST partnership. Binks P, et al. Among authors: davies j. BMC Health Serv Res. 2024 Jun 7;24(1):710. doi: 10.1186/s12913-024-11149-y. BMC Health Serv Res. 2024. PMID: 38849881 Free PMC article.
Evaluating a novel model of hepatitis B care, Hep B PAST, in the Northern Territory of Australia: results from a prospective, population-based study.
Hosking K, Binks P, De Santis T, Wilson PM, Gurruwiwi GG, Bukulatjpi SM, Vintour-Cesar E, McKinnon M, Nihill P, Fernandes TA, Greenwood-Smith B, Batey R, Ross C, Tong SYC, Stewart G, Marshall C, Gargan C, Manchikanti P, Fuller K, Tate-Baker J, Stewart S, Cowie B, Allard N, MacLachlan JH, Qama A, Boettiger D, Davis JS, Connors C, Davies J; Hep B PAST partnership. Hosking K, et al. Among authors: davies j. Lancet Reg Health West Pac. 2024 Jun 12;48:101116. doi: 10.1016/j.lanwpc.2024.101116. eCollection 2024 Jul. Lancet Reg Health West Pac. 2024. PMID: 38966601 Free PMC article.
Engagement and partnership with consumers and communities in the co-design and conduct of Research: Lessons from the INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis (INFERR) clinical trial.
Long S, Ross C, Koops J, Coulthard K, Nelson J, Shapkota AK, Hewett L, Tate-Baker J, Graham J, Mukula R, Tetteh C, Hoppo L, Cherian S, Pawar B, Chmielewski HL, Gold LM, Rathnayake G, Heron B, Brewster-O'Brien T, Karepalli V, Maple-Brown L, Batey R, Morris P, Davies J, Fernandes DK, Thomas S, Abeyaratne A, Lawton PD, Barzi F, Taylor S, Mayo M, Cass A, Majoni SW. Long S, et al. Among authors: davies j. Res Involv Engagem. 2024 Jul 15;10(1):73. doi: 10.1186/s40900-024-00608-9. Res Involv Engagem. 2024. PMID: 39010175 Free PMC article.
"They feel shame sometime, but that is why we need to talk to them…we need to tell them how important it is not to feel shame": Hepatitis B related shame and improving hepatitis B care in Aboriginal and Torres Strait Islander communities in the Top End of the Northern Territory, according to the Aboriginal health workforce.
Sullivan RP, Bukulatjpi SM, Binks P, Hosking K, Nundhirribala P, Vintour-Cesar E, McKinnon M, Gurruwiwi G, Green A, Davis JS, Davies J. Sullivan RP, et al. Among authors: davies j. Arch Public Health. 2024 Sep 11;82(1):151. doi: 10.1186/s13690-024-01389-z. Arch Public Health. 2024. PMID: 39261962 Free PMC article.
Combination of Antistaphylococcal β-Lactam With Standard Therapy Compared to Standard Therapy Alone for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the CAMERA2 Trial Using a Desirability of Outcome Ranking Approach.
Petersiel N, Davis JS, Meagher N, Price DJ, Tong SYC; Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA2) Study Group. Petersiel N, et al. Open Forum Infect Dis. 2024 Apr 25;11(5):ofae181. doi: 10.1093/ofid/ofae181. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38698894 Free PMC article.
Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial.
Petersiel N, Giulieri S, Daniel DS, Fan S-H, Ersoy SC, Davis JS, Bayer AS, Howden BP, Tong SYC; CAMERA2 study group. Petersiel N, et al. Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0021824. doi: 10.1128/aac.00218-24. Epub 2024 Jun 5. Antimicrob Agents Chemother. 2024. PMID: 38837393 Free PMC article. Clinical Trial.
7,607 results